The people behind the ideas.
The ideas behind the companies.
Common Room’s
Linda Lian
on integrating community into your company 
Pendulum’s
Mark Listes
on finding hidden narratives in social media 
OctoML’s
Luis Ceze
on bringing ML to all platforms 
Flexe’s
Karl Siebrecht
on transforming the logistics industry 
Spotnana’s
Sarosh Waghmar
on challenging a decades-old industry 
Highspot’s
Robert Wahbe
on customers, AI, and building relationships that last 
Nautilus Bio’s
Sujal Patel and Parag Mallick
on the proteome 
SeekOut’s
Anoop Gupta
on hiring and untapped talent pools 
Rover’s
Aaron Easterly
on the love of pets and finding the right partners 
RelationalAI’s
Molham Aref
on finding investors who believe in your passion 
Statsig’s
Vijaye Raji
on using data to build better products 
Crowd Cow’s
Elizabeth Liu
on the power of e-commerce to transform an industry Company List
Category:
-
Envisagenics is an Artificial Intelligence-driven biotechnology company that focuses on the discovery of novel RNA splicing variants that cause cancer and other genetic diseases. Its principal technology is the SpliceCore® discovery platform. The platform re-envisions the human genome with a validated exon-centric approach, combined with machine learning algorithms and high-performance computing. It is up to 250 times more likely to discover novel targets than gene-centric discovery tools. Using innovative technology and RNA analysis expertise, Envisagenics accelerates the development of highly specific therapeutics that modulate RNA splicing events that drive pathogenesis of oncology, neurodegenerative, and metabolic disorders.Initial Investment2018Envisagenics is an Artificial Intelligence-driven biotechnology company that focuses on the discovery of novel RNA splicing variants that cause cancer and other genetic diseases. Its principal technology is the SpliceCore® discovery platform. The platform re-envisions the human genome with a validated exon-centric approach, combined with machine learning algorithms and high-performance computing. It is up to 250 times more likely to discover novel targets than gene-centric discovery tools. Using innovative technology and RNA analysis expertise, Envisagenics accelerates the development of highly specific therapeutics that modulate RNA splicing events that drive pathogenesis of oncology, neurodegenerative, and metabolic disorders. -
Based in Seattle, Washington, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bioInitial Investment2018Based in Seattle, Washington, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bioFoundersSujal Petal
Parag MallickInvestment JourneyPublic June 2021
NASDAQ: NAUTInitial Investment2018 -
Ovation is a next-generation clinical informatics company.Initial Investment2019Ovation is a next-generation clinical informatics company. -
TwinStrand Biosciences is a Seattle genomics company building a platform around Duplex Sequencing, a proprietary process that helps physicians, patients and drug researchers make life saving decisions faster based on DNA data.Initial Investment2019TwinStrand Biosciences is a Seattle genomics company building a platform around Duplex Sequencing, a proprietary process that helps physicians, patients and drug researchers make life saving decisions faster based on DNA data.